Literature DB >> 2948607

Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist.

E J Thomas, J Jenkins, E A Lenton, I D Cooke.   

Abstract

Mesh：

Substances：

Year:  1986        PMID： 2948607      PMCID： PMC1342173          DOI： 10.1136/bmj.293.6559.1407-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  1 in total

1.  Biodegradable sustained release formulation of the LH-RH analogue 'Zoladex' for the treatment of hormone-responsive tumours.

Authors:  B J Furr; F G Hutchinson
Journal:  Prog Clin Biol Res       Date:  1985
  1 in total
  9 in total

Review 1.  Goserelin: a review of its use in the treatment of early breast cancer in premenopausal and perimenopausal women.

Authors:  Susan M Cheer; Greg L Plosker; Dene Simpson; Antona J Wagstaff
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  Successful treatment of infertility due to polycystic ovary disease using a combination of luteinising hormone releasing hormone agonist and low dosage menotrophin.

Authors:  M Armitage; T Wilkin; K Dewbury
Journal:  Br Med J (Clin Res Ed)       Date:  1987-07-11

Review 3.  Acne and psoriasis.

Authors:  G M Murphy; M W Greaves
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-20

4.  Two different formulations with equivalent effect? Comparison of serum estradiol suppression with monthly goserelin and trimonthly leuprolide in breast cancer patients.

Authors:  Adnan Aydiner; Leyla Kilic; Ibrahim Yildiz; Serkan Keskin; Fatma Sen; Seden Kucucuk; Hasan Karanlik; Mahmut Muslumanoglu; Abdullah Igci
Journal:  Med Oncol       Date:  2012-12-29       Impact factor: 3.064

Review 5.  Clinical pharmacokinetics of goserelin.

Authors:  I D Cockshott
Journal:  Clin Pharmacokinet       Date:  2000-07       Impact factor: 6.447

Review 6.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical use in sex hormone-related conditions.

Authors:  P Chrisp; K L Goa
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 7.  Goserelin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in benign gynaecological disorders.

Authors:  C M Perry; R N Brogden
Journal:  Drugs       Date:  1996-02       Impact factor: 9.546

8.  Shrinkage of uterine fibroids by preoperative LHRH analogue injection.

Authors:  H R McClelland; A J Quinn
Journal:  Ulster Med J       Date:  1992-04

9.  Luteinizing hormone-releasing hormone analogues--the rationale for adjuvant use in premenopausal women with early breast cancer.

Authors:  W Jonat
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.